Header Logo

Julio Morales

Concepts (180)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
DNA Repair
11
2020
82
1.530
Why?
Exoribonucleases
3
2022
20
1.470
Why?
Brain Neoplasms
2
2022
301
1.140
Why?
DNA Damage
10
2020
151
1.000
Why?
Glioblastoma
1
2022
105
0.710
Why?
Neoplasm Proteins
4
2020
123
0.710
Why?
Cell Cycle Proteins
5
2018
187
0.700
Why?
DNA Polymerase I
1
2020
1
0.690
Why?
Tumor Suppressor p53-Binding Protein 1
5
2016
6
0.670
Why?
Genomic Instability
5
2020
34
0.660
Why?
Up-Regulation
1
2020
246
0.630
Why?
Poly(ADP-ribose) Polymerases
3
2020
22
0.630
Why?
Glioma
1
2020
117
0.620
Why?
Phosphoproteins
5
2006
117
0.610
Why?
DNA Replication
2
2020
51
0.550
Why?
Intracellular Signaling Peptides and Proteins
5
2006
281
0.520
Why?
Transcription, Genetic
1
2016
403
0.460
Why?
Transcription Termination, Genetic
1
2014
1
0.450
Why?
Gene Expression Regulation, Neoplastic
4
2020
461
0.410
Why?
Neoplasms
4
2016
803
0.410
Why?
DNA Breaks, Double-Stranded
4
2020
26
0.350
Why?
DNA-Binding Proteins
8
2020
490
0.340
Why?
Cell Movement
2
2022
365
0.320
Why?
Mice
10
2022
4621
0.280
Why?
Tumor Suppressor Protein p53
3
2008
103
0.270
Why?
Carrier Proteins
3
2004
252
0.270
Why?
Animals
12
2022
10370
0.270
Why?
Thymus Neoplasms
1
2006
8
0.260
Why?
Lymphoma
1
2006
25
0.250
Why?
Humans
18
2022
27968
0.250
Why?
Cell Line, Tumor
6
2020
1314
0.240
Why?
Radiation-Sensitizing Agents
2
2016
32
0.240
Why?
Breast Neoplasms
2
2020
458
0.220
Why?
Naphthoquinones
2
2014
11
0.220
Why?
HeLa Cells
4
2020
208
0.210
Why?
DNA Mismatch Repair
2
2016
12
0.210
Why?
RNA Helicases
3
2020
8
0.210
Why?
Chromosome Aberrations
1
2003
37
0.210
Why?
Neoplastic Processes
1
2022
4
0.200
Why?
RNA, Neoplasm
1
2020
24
0.180
Why?
Nuclear Proteins
3
2014
247
0.180
Why?
Poly (ADP-Ribose) Polymerase-1
1
2020
8
0.170
Why?
Mutation
3
2018
843
0.170
Why?
Etoposide
1
2020
19
0.170
Why?
Antineoplastic Agents
3
2016
679
0.170
Why?
Radiation, Ionizing
1
2020
25
0.170
Why?
Indazoles
1
2020
18
0.170
Why?
Transcription Factors
2
2014
520
0.170
Why?
RNA, Messenger
1
2022
657
0.160
Why?
Piperidines
1
2020
48
0.160
Why?
Survival Analysis
1
2020
287
0.160
Why?
DNA End-Joining Repair
2
2020
3
0.160
Why?
Cell Proliferation
1
2022
802
0.150
Why?
Genes, BRCA2
1
2018
10
0.150
Why?
Genes, BRCA1
1
2018
12
0.150
Why?
Proto-Oncogene Proteins c-abl
2
2008
3
0.150
Why?
Intracranial Aneurysm
1
2019
57
0.150
Why?
Stents
1
2019
120
0.150
Why?
Cells, Cultured
2
2014
984
0.140
Why?
Cell Nucleus
2
2016
136
0.140
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2018
37
0.140
Why?
Disease Models, Animal
3
2018
1454
0.130
Why?
MicroRNAs
1
2020
294
0.130
Why?
Neurosurgical Procedures
1
2019
217
0.130
Why?
Multifunctional Enzymes
1
2016
1
0.130
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2016
8
0.130
Why?
Plasmids
1
2016
126
0.130
Why?
DNA Helicases
1
2016
51
0.130
Why?
Proto-Oncogene Proteins p21(ras)
1
2016
63
0.130
Why?
Microscopy, Fluorescence
1
2016
163
0.120
Why?
Genomics
1
2016
122
0.120
Why?
RNA, Small Interfering
1
2016
198
0.120
Why?
Chromosomal Proteins, Non-Histone
3
2006
77
0.120
Why?
Protein Structure, Tertiary
2
2014
284
0.120
Why?
Mice, Knockout
4
2006
836
0.120
Why?
Quinones
1
2014
23
0.110
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2014
40
0.110
Why?
Endonucleases
1
2014
17
0.110
Why?
Bystander Effect
1
2014
16
0.110
Why?
Histones
2
2006
92
0.110
Why?
Triple Negative Breast Neoplasms
1
2014
36
0.110
Why?
Necrosis
1
2014
83
0.110
Why?
Nanomedicine
1
2014
62
0.100
Why?
Enzyme Inhibitors
1
2014
249
0.100
Why?
Saccharomyces cerevisiae Proteins
1
2014
112
0.100
Why?
Molecular Targeted Therapy
1
2014
135
0.100
Why?
Epigenesis, Genetic
1
2014
147
0.100
Why?
Lung Neoplasms
1
2016
353
0.100
Why?
Xenograft Model Antitumor Assays
3
2018
268
0.090
Why?
G2 Phase
3
2008
15
0.090
Why?
Repressor Proteins
2
2016
118
0.090
Why?
Synthetic Lethal Mutations
2
2020
4
0.080
Why?
Fluorouracil
1
2009
58
0.080
Why?
Antimetabolites, Antineoplastic
1
2009
48
0.080
Why?
A549 Cells
2
2020
16
0.080
Why?
Tumor Suppressor Proteins
1
2008
49
0.070
Why?
Immunoglobulin Class Switching
2
2006
10
0.070
Why?
Adaptor Proteins, Signal Transducing
1
2008
163
0.070
Why?
Chromosomes, Mammalian
1
2006
6
0.060
Why?
Protein-Arginine N-Methyltransferases
1
2005
3
0.060
Why?
Cytosol
1
2006
47
0.060
Why?
Phosphorylation
2
2004
574
0.060
Why?
Female
6
2020
15074
0.060
Why?
Cell Transformation, Neoplastic
1
2006
119
0.060
Why?
Survival Rate
1
2006
428
0.060
Why?
X-ray Repair Cross Complementing Protein 1
1
2004
1
0.060
Why?
Apoptosis
1
2008
772
0.060
Why?
Immunoglobulin Constant Regions
1
2004
3
0.060
Why?
Casein Kinase II
1
2004
17
0.060
Why?
Mice, Nude
2
2016
330
0.060
Why?
Carcinoma, Renal Cell
1
2004
77
0.050
Why?
Kidney Neoplasms
1
2004
101
0.050
Why?
Terminal Repeat Sequences
1
2003
2
0.050
Why?
Active Transport, Cell Nucleus
1
2003
17
0.050
Why?
Growth
1
2003
24
0.050
Why?
BRCA1 Protein
1
2003
24
0.050
Why?
Genome
1
2003
56
0.050
Why?
Mitosis
1
2002
112
0.050
Why?
Models, Biological
3
2009
466
0.050
Why?
Tomography, X-Ray Computed
1
2004
473
0.050
Why?
Autoimmune Diseases
1
2003
164
0.050
Why?
Epithelial-Mesenchymal Transition
1
2020
114
0.040
Why?
HEK293 Cells
1
2020
186
0.040
Why?
Angiography, Digital Subtraction
1
2019
19
0.040
Why?
CDC2 Protein Kinase
1
2018
15
0.040
Why?
Equipment Design
1
2019
217
0.040
Why?
Genes, Reporter
1
2018
87
0.040
Why?
Endovascular Procedures
1
2019
69
0.040
Why?
Signal Transduction
3
2009
1433
0.040
Why?
Promoter Regions, Genetic
1
2018
343
0.030
Why?
Dose-Response Relationship, Drug
2
2008
604
0.030
Why?
Follow-Up Studies
1
2019
1011
0.030
Why?
DNA Topoisomerases, Type I
1
2016
7
0.030
Why?
RNA Polymerase II
1
2016
7
0.030
Why?
Ku Autoantigen
1
2016
12
0.030
Why?
Antigens, Nuclear
1
2016
22
0.030
Why?
RNA Interference
1
2016
137
0.030
Why?
Multiprotein Complexes
1
2016
54
0.030
Why?
Protein Kinase Inhibitors
1
2016
156
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2016
105
0.030
Why?
Postoperative Complications
1
2019
611
0.030
Why?
Aged, 80 and over
1
2019
2015
0.030
Why?
Aged
2
2019
5383
0.030
Why?
Tumor Cells, Cultured
1
2014
315
0.030
Why?
B-Lymphocytes
2
2006
282
0.030
Why?
Oxidation-Reduction
1
2014
364
0.030
Why?
Treatment Outcome
1
2019
2367
0.020
Why?
Middle Aged
2
2019
7111
0.020
Why?
MutL Protein Homolog 1
1
2008
1
0.020
Why?
Tumor Protein p73
1
2008
2
0.020
Why?
Methylnitronitrosoguanidine
1
2008
2
0.020
Why?
Base Pair Mismatch
1
2008
7
0.020
Why?
Cytoplasm
1
2008
57
0.020
Why?
Imatinib Mesylate
1
2008
14
0.020
Why?
Benzamides
1
2008
34
0.020
Why?
Models, Genetic
1
2008
125
0.020
Why?
Piperazines
1
2008
47
0.020
Why?
Male
2
2019
13424
0.020
Why?
Cell Cycle
1
2008
161
0.020
Why?
Pyrimidines
1
2008
125
0.020
Why?
Colonic Neoplasms
1
2008
120
0.020
Why?
Chromosome Breakage
1
2006
1
0.020
Why?
Immunoglobulin Heavy Chains
1
2006
10
0.020
Why?
Cytidine Deaminase
1
2006
8
0.020
Why?
Methylation
1
2005
24
0.020
Why?
Translocation, Genetic
1
2006
23
0.020
Why?
Biopolymers
1
2005
15
0.020
Why?
In Situ Hybridization, Fluorescence
1
2006
75
0.020
Why?
Arginine
1
2005
39
0.020
Why?
Glycine
1
2005
31
0.020
Why?
In Vitro Techniques
1
2006
241
0.020
Why?
Recombination, Genetic
1
2005
62
0.020
Why?
Stem Cells
1
2005
121
0.010
Why?
Amino Acid Sequence
1
2005
687
0.010
Why?
Molecular Sequence Data
1
2005
1048
0.010
Why?
Checkpoint Kinase 2
1
2002
3
0.010
Why?
Protein Kinases
1
2002
148
0.010
Why?
Cell Line
1
2002
695
0.010
Why?
Gene Expression Regulation
1
2002
632
0.010
Why?
Retrospective Studies
1
2004
2541
0.010
Why?
Morales's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (180)
Explore
_
Co-Authors (2)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_